derivative sub-AAV8-IP-04 AAV8 -CG-IP-04.jpx (File)

Project:

OT2OD024912

Project (Entity type)

Id Namespace:

SPARC file namespace

Identifier Namespace (Entity type)

File Format:

MAT

File Format (Entity type)

Dcc Asset:

C2M2 datapackage 202509.zip

Processed File (Entity type)

Dcc:

SPARC

DCC (Entity type)

Data Type:

experimental measurement

Data Type (Entity type)

Assay Type:

electrophysiology assay

Assay Type (Entity type)

Uncompressed Size In Bytes:6.07 MB

Size In Bytes:6.07 MB

Sha256:b3644f71d07a65bd2447500a8c6eb63838f478daeb21688cbcedd9bdede5e90d

Persistent Id:sparc.drs:package/dda45df7-fc6f-4f22-96f6-fac3b5cb1d94

Mime Type:application/x-matlab-data

Filename:derivative__sub-AAV8-IP-04__AAV8_-CG-IP-04.jpx

Creation Time:2022-12-13T15:43:03+00:00

Access Url:

https://services.scicrunch.io/sparc/drs/v1/package/dda45df7-fc6f-4f22-96f6-fac3b5cb1d94

Results found

Linked to

	Label	Description
	N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e Collection (Entity type)	Assessment of AAV serotypes 6, 8 and 9 for targeting pancreatic innervation.
	N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e AAV8-IP-04 Subject (Entity type)	A subject from SPARC produced as part of the OT2OD024912 project
	N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e AAV8-IP-04 default Biosample (Entity type)	A biosample from SPARC produced as part of the OT2OD024912 project

N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e

Collection (Entity type)

Assessment of AAV serotypes 6, 8 and 9 for targeting pancreatic innervation.

N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e AAV8-IP-04

Subject (Entity type)

A subject from SPARC produced as part of the OT2OD024912 project

N:dataset:fce3f57f-18ea-4453-887e-58a885e90e7e AAV8-IP-04 default

Biosample (Entity type)

A biosample from SPARC produced as part of the OT2OD024912 project

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.